---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-007671"
form_type: "8-K"
ticker: "PAYS"
cik: "0001496443"
company_name: "Paysign, Inc."
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T14:44:35.167059+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Paysign Q3 revenue up 17% to $12.4M; net income $1.1M; pharma revenue +142%

## Summary
- Q3 total revenues $12.4M (+17% YoY); net income $1.1M, diluted EPS $0.02.
- Adjusted EBITDA $2.3M (+22% YoY); plasma revenue +13%, pharma patient affordability revenue +142%.
- Added 19 new plasma centers (462 total); avg revenue per plasma center per month $8,102 (+7.8% YoY).
- Exited quarter with $9.9M unrestricted cash, zero debt; repurchased 75k shares for $150k.
- FY2023 guidance reaffirmed: revenue $44-46M, Adj. EBITDA $6-7.5M; Q4 growth expected slightly above 17%.

## SEC filing metadata
- accession: 0001683168-23-007671
- form_type: 8-K
- ticker: PAYS
- cik: 0001496443
- company_name: Paysign, Inc.
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1496443/000168316823007671/0001683168-23-007671-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1496443/000168316823007671/paysign_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-007671
- JSON: https://secwatch.observer/filing/0001683168-23-007671.json
- Plain text: https://secwatch.observer/filing/0001683168-23-007671.txt

## Key facts
- Earnings Releases
  Paysign, Inc. reported financial results for the fiscal quarter ended September 30, 2023.
  - Period: the fiscal quarter ended September 30, 2023
  - Result: reported results
  source text: On November 7, 2023, we issued a press release regarding our financial results for the fiscal quarter ended September 30, 2023. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1496443/000168316823007671/0001683168-23-007671-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.